Latest Institutional Purchases of Protara Therapeutics, Inc. (TARA)
This list provides information on the latest institutional transactions involving Protara Therapeutics, Inc. (TARA) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Semmax Financial Advisors Inc.
Winston Salem, NC |
BUY
|
- |
1.57KNew |
$2.67K - $3.77K
|
1.57K
$5.85K
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
BUY
|
- |
373New |
$634 - $895
|
373
$1.39K
|
|
Q2 2024 | |||||||
Aug 14, 2024
Q2 2024
|
Boxer Capital, LLC
San Diego, CA |
BUY
|
- |
602K+ 287.92% |
$1.18M - $2.49M
|
812K
$3.02M
|
|
Aug 14, 2024
Q2 2024
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
520KNew |
$1.02M - $2.15M
|
520K
$1.93M
|
|
Aug 14, 2024
Q2 2024
|
Baker Bros. Advisors LP
New York, NY |
BUY
|
- |
337K+ 168.86% |
$661K - $1.4M
|
537K
$2M
|
|
Aug 15, 2024
Q2 2024
|
Cvi Holdings, LLC
Wilmington, DE |
BUY
|
- |
303KNew |
$593K - $1.25M
|
303K
$1.13M
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
BUY
|
- |
84.4K+ 273.49% |
$165K - $349K
|
115K
$429K
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
77.4KNew |
$152K - $320K
|
77.4K
$288K
|
|
Q1 2024 | |||||||
May 13, 2024
Q1 2024
|
Stem Point Capital LP
New York, NY |
BUY
|
CALL |
87.9KNew |
$163K - $425K
|
87.9K
$327K
|
|
May 15, 2024
Q1 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
17.4KNew |
$32.4K - $84K
|
17.4K
$64.7K
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
22New |
$40.9 - $106
|
22
$81.8
|
|
Q3 2023 | |||||||
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
2New |
$3.28 - $5.86
|
2
$7.44
|
|
Q2 2023 | |||||||
Jul 25, 2023
Q2 2023
|
Privium Fund Management B.V.
|
BUY
|
- |
120KNew |
$272K - $430K
|
120K
$445K
|
|
Q4 2022 | |||||||
Feb 14, 2023
Q4 2022
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
17.9KNew |
$43.5K - $66.3K
|
17.9K
$66.6K
|
|
Feb 10, 2023
Q4 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
100New |
$243 - $370
|
100
$372
|
|
Q3 2022 | |||||||
Nov 07, 2022
Q3 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
2.36K+ 23.38% |
$6.99K - $10.1K
|
12.5K
$46.4K
|
|
Nov 14, 2022
Q3 2022
|
Financial Advocates Investment Management
Olympia, WA |
BUY
|
- |
1.16KNew |
$3.44K - $4.96K
|
1.16K
$4.32K
|
|
Mar 17, 2023
Q3 2022
|
American Portfolios Advisors
Holbrook, NY |
BUY
|
- |
100New |
$296 - $427
|
100
$372
|
|
Q1 2021 | |||||||
May 17, 2021
Q1 2021
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
35K+ 47.04% |
$481K - $835K
|
109K
$407K
|
|
Q4 2020 | |||||||
Nov 08, 2023
Q4 2020
|
Eversept Partners, LP
New York, NY |
BUY
|
- |
36.3KNew |
$616K - $920K
|
36.3K
$135K
|
|
Q3 2020 | |||||||
Nov 16, 2020
Q3 2020
|
Farallon Capital Management LLC
San Francisco, CA |
BUY
|
- |
425KNew |
$7.12M - $13.6M
|
425K
$1.58M
|